A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,694,300 shares of MRK stock, worth $263 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,694,300
Previous 2,438,100 10.51%
Holding current value
$263 Million
Previous $302 Million 1.37%
% of portfolio
0.06%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $133 Million - $155 Million
-1,200,378 Reduced 14.56%
7,041,689 $800 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $82.6 Million - $88.7 Million
666,847 Added 8.8%
8,242,067 $1.02 Billion
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $142 Million - $166 Million
1,257,049 Added 19.9%
7,575,220 $1 Billion
Q4 2023

Feb 14, 2024

SELL
$100.18 - $109.02 $36 Million - $39.1 Million
-358,936 Reduced 5.38%
6,318,171 $689 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $498 Million - $553 Million
4,837,236 Added 262.91%
6,677,107 $687 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $116 Million - $127 Million
1,068,727 Added 138.59%
1,839,871 $212 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $177 Million - $197 Million
-1,715,524 Reduced 68.99%
771,144 $82 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $78.7 Million - $101 Million
-900,548 Reduced 26.59%
2,486,668 $276 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $104 Million - $117 Million
1,231,726 Added 57.14%
3,387,216 $292 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $103 Million - $117 Million
-1,233,115 Reduced 36.39%
2,155,490 $197 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $86.1 Million - $96.5 Million
1,171,399 Added 52.83%
3,388,605 $278 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $63 Million - $78.9 Million
-871,326 Reduced 28.21%
2,217,206 $170 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $9.92 Million - $10.9 Million
138,422 Added 4.69%
3,088,532 $232 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $101 Million - $111 Million
-1,431,650 Reduced 32.67%
2,950,110 $229 Million
Q1 2021

May 17, 2021

SELL
$68.86 - $81.11 $38.5 Million - $45.4 Million
-559,774 Reduced 11.33%
4,381,760 $338 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $203 Million - $226 Million
2,833,384 Added 134.4%
4,941,534 $404 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $56.8 Million - $64.4 Million
776,626 Added 58.33%
2,108,150 $175 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $7.2 Million - $8.19 Million
-102,236 Reduced 7.13%
1,331,524 $103 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $31.5 Million - $43.6 Million
496,742 Added 53.01%
1,433,760 $110 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $132 Million - $149 Million
-1,707,170 Reduced 64.56%
937,018 $85.2 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $148 Million - $162 Million
1,950,861 Added 281.38%
2,644,188 $212 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $40.3 Million - $47.1 Million
-577,166 Reduced 45.43%
693,327 $58.1 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $39.2 Million - $44.7 Million
-563,408 Reduced 30.72%
1,270,493 $0
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $217 Million - $252 Million
-3,331,026 Reduced 64.49%
1,833,901 $134 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $111 Million - $131 Million
1,926,113 Added 59.47%
5,164,927 $0
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $144 Million - $169 Million
-2,825,198 Reduced 46.59%
3,238,814 $0
Q1 2018

May 11, 2018

SELL
$50.96 - $59.23 $120 Million - $140 Million
-2,364,413 Reduced 28.05%
6,064,012 $330 Million
Q4 2017

Feb 09, 2018

BUY
$51.62 - $61.64 $402 Million - $480 Million
7,792,358 Added 1225.08%
8,428,425 $474 Million
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $37.3 Million - $40.2 Million
636,067
636,067 $40.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.